IVA
CVS icon

International Value Advisers’s CVS Health CVS Stock Holding History

International Value Advisers’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-707,662
Closed -$59.2M – 24
2018
Q4 		$59.2M Sell
707,662
-44,054
-6% -$3.29M 1.8% 19
2018
Q3 		$59.2M Sell
751,716
-22,192
-3% -$1.59M 1.62% 22
2018
Q2 		$49.8M Sell
773,908
-37,441
-5% -$2.47M 1.35% 24
2018
Q1 		$50.5M Sell
811,349
-370,173
-31% -$26.6M 1.42% 23
2017
Q4 		$85.7M Sell
1,181,522
-1,021,529
-46% -$74.3M 2.46% 16
2017
Q3 		$179M Sell
2,203,051
-71,138
-3% -$5.63M 5.39% 5
2017
Q2 		$183M Sell
2,274,189
-8,146
-0.4% -$643K 5.65% 6
2017
Q1 		$179M Sell
2,282,335
-366
-0% -$29.2K 5.7% 6
2016
Q4 		$180M Buy
2,282,701
+1,129,387
+98% +$91.4M 6.07% 5
2016
Q3 		$103M Sell
1,153,314
-63,988
-5% -$6.04M 3.03% 10
2016
Q2 		$117M Sell
1,217,302
-29,494
-2% -$2.94M 3.45% 10
2016
Q1 		$129M Sell
1,246,796
-83,292
-6% -$8.1M 3.75% 9
2015
Q4 		$130M Sell
1,330,088
-14,563
-1% -$1.43M 3.44% 10
2015
Q3 		$130M Sell
1,344,651
-86,200
-6% -$9.06M 3.4% 10
2015
Q2 		$150M Sell
1,430,851
-5,414
-0.4% -$553K 3.88% 10
2015
Q1 		$148M Sell
1,436,265
-7,545
-0.5% -$763K 3.73% 11
2014
Q4 		$139M Sell
1,443,810
-2,385
-0.2% -$210K 3.17% 13
2014
Q3 		$115M Buy
1,446,195
+15,757
+1% +$1.24M 2.61% 16
2014
Q2 		$108M Buy
1,430,438
+36,434
+3% +$2.75M 2.49% 17
2014
Q1 		$104M Buy
1,394,004
+450
+0% +$31.8K 2.51% 16
2013
Q4 		$99.7M Buy
1,393,554
+16,382
+1% +$1.05M 2.48% 17
2013
Q3 		$78.2M Buy
1,377,172
+2,391
+0.2% +$142K 2.05% 19
2013
Q2 		$78.6M Buy
+1,374,781
New +$79.6M 2.09% 19

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

International Value Advisers's CVS Position: Q1 2019 in Review

International Value Advisers sold out of CVS Health (CVS) in Q1 2019, closing a stake of 707,662 shares — an estimated $59.2M sold.

International Value Advisers first reported a position in CVS in Q2 2013 and held it in 23 quarters. The position peaked at $183M in Q2 2017. 1,707 funds tracked by Wall St. Rank hold CVS as of Q1 2019.

  • International Value Advisers reported no remaining CVS Health position as of Q1 2019 after selling out during the quarter.
  • International Value Advisers sold 707,662 CVS Health shares in Q1 2019, an estimated $59.2M.
  • International Value Advisers first reported a position in CVS Health in Q2 2013 and held it in 23 quarters.
  • International Value Advisers's CVS Health position peaked at $183M in Q2 2017.
  • 1,707 funds tracked by Wall St. Rank held CVS Health as of Q1 2019.

Based on International Value Advisers's 13F filing for Q1 2019, filed 14 May 2019.